Jane Street
RXST icon

Jane Street’s RxSight RXST Stock Holding History

Jane Street’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Sell
223,904
-14,067
-6% -$117K ﹤0.01% 5804
2025
Q4 		$2.48M Buy
237,971
+150,846
+173% +$1.51M ﹤0.01% 4415
2025
Q3 		$783K Buy
87,125
+24,198
+38% +$212K ﹤0.01% 6852
2025
Q2 		$818K Buy
62,927
+26,029
+71% +$391K ﹤0.01% 5995
2025
Q1 		$932K Sell
36,898
-46,585
-56% -$1.38M ﹤0.01% 5697
2024
Q4 		$2.87M Buy
83,483
+47,012
+129% +$2.12M ﹤0.01% 3523
2024
Q3 		$1.8M Sell
36,471
-15,276
-30% -$783K ﹤0.01% 4701
2024
Q2 		$3.11M Buy
51,747
+31,444
+155% +$1.8M ﹤0.01% 3751
2024
Q1 		$1.05M Sell
20,303
-48,402
-70% -$2.38M ﹤0.01% 5334
2023
Q4 		$2.77M Buy
+68,705
New +$2.02M ﹤0.01% 3773
2023
Q3 		– Sell
-71,680
Closed -$2.14M – 9277
2023
Q2 		$2.06M Buy
71,680
+54,360
+314% +$1.21M ﹤0.01% 4121
2023
Q1 		$289K Buy
+17,320
New +$245K ﹤0.01% 7263

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Jane Street's RXST Position: Q1 2026 in Review

Jane Street reduced its RxSight (RXST) stake by 5.9% in Q1 2026, selling an estimated $117K and leaving 223,904 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5804.

Jane Street first reported a position in RXST in Q1 2023 and has held it in 12 quarters since. The position peaked at $3.11M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Jane Street held 223,904 shares of RxSight worth $1.38M as of Q1 2026.
  • Jane Street sold 14,067 RxSight shares in Q1 2026, an estimated $117K.
  • RxSight made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5804 holding.
  • Jane Street first reported a position in RxSight in Q1 2023 and has held it in 12 quarters since.
  • Jane Street's RxSight position peaked at $3.11M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.